Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T04:41:22.702Z Has data issue: false hasContentIssue false
  • English
  • Français

Lifetime hormonal factors may predict late-life depression in women

Published online by Cambridge University Press:  05 June 2008

Joanne Ryan ,
Isabelle Carrière ,
Jacqueline Scali ,
Karen Ritchie  and
Marie-Laure Ancelin
Joanne Ryan*
Affiliation:
Inserm, U888, Montpellier, F-34093France; Univ Montpellier 1, Montpellier, F-34000France
Isabelle Carrière
Affiliation:
Inserm, U888, Montpellier, F-34093France; Univ Montpellier 1, Montpellier, F-34000France
Jacqueline Scali
Affiliation:
Inserm, U888, Montpellier, F-34093France; Univ Montpellier 1, Montpellier, F-34000France
Karen Ritchie
Affiliation:
Inserm, U888, Montpellier, F-34093France; Univ Montpellier 1, Montpellier, F-34000France
Marie-Laure Ancelin
Affiliation:
Inserm, U888, Montpellier, F-34093France; Univ Montpellier 1, Montpellier, F-34000France
*
Correspondence should be addressed to: Joanne Ryan, Inserm U888, Nervous System Pathologies: Epidemiological and Clinical Research, Hôpital La Colombière, 39 av. Ch. Flahault, BP 34493, 34093 Montpellier Cedex 5, France. Phone: +33 499 614 562; Fax: +33 499 614 579. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Fluctuating hormone levels are known to influence a woman's mood and well-being. This study aimed to determine whether lifetime hormonal markers are associated with late-life depression symptoms among elderly community-dwelling women.

Method: Detailed reproductive histories of 1013 women aged 65 years and over were obtained using questionnaires, and depressive symptoms were assessed using the Centre for Epidemiological Studies Depression Scale. Multivariate logistic regression models were generated to determine whether any lifetime endogenous or exogenous hormonal factors were associated with late-life depression.

Results: The prevalence of depressive symptoms was 17%. Age at menopause was associated with depressive symptoms, but only among women with a lower education level. For these women, an earlier age at menopause increased their risk of late-life depression (linear effect, OR = 0.95, 95%CI: 0.91–0.99). The odds of late-life depression were also increased for women who were past (OR = 1.6, 95%CI: 1.1–2.5), but were not current users. On the other hand, long-term oral contraceptive use (≥10 years) was protective against depression (OR = 0.3, 95%CI: 0.1–0.9). These associations remained significant even after extensive adjustment for a range of potential confounding factors, including sociodemographic factors, mental and physical incapacities, antidepressant use and past depression. The other factors examined – including age at first menses, parity, age at childbirth and surgical menopause – were not associated with late-life depressive symptoms.

Conclusions: Lifetime hormonal factors that are significantly associated with depression symptoms in later life have been identified. Further work is needed to determine how potential hormonal interventions could be used in the treatment of late-life depression in certain subgroups of women.

Keywords

lifetime hormonal exposureestrogendepressionlate-life
Type
Research Article
Information
International Psychogeriatrics , Volume 20 , Issue 6 , December 2008 , pp. 1203 - 1218
Copyright
Copyright © International Psychogeriatric Association 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ancelin, M. L., Scali, J. and Ritchie, K. (2007). Hormonal therapy and depression: Are we overlooking an important therapeutic alternative? Journal of Psychosomatic Research, 62, 473–485.CrossRefGoogle ScholarPubMed
Anderson, G. L. et al. (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 291, 1701–1712.Google ScholarPubMed
Andrade, T. G., Nakamuta, J. S., Avanzi, V. and Graeff, F. G. (2005). Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behavioural Brain Research, 163, 18–25.CrossRefGoogle ScholarPubMed
Bean, J. A., Leeper, J. D., Wallace, R. B., Sherman, B. M. and Jagger, H. (1979). Variations in the reporting of menstrual histories. American Journal of Epidemiology, 109, 181–185.CrossRefGoogle ScholarPubMed
Berkman, L. F. et al. (1986). Depressive symptoms in relation to physical health and functioning in the elderly. American Journal of Epidemiology, 124, 372–388.CrossRefGoogle ScholarPubMed
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L. and Rubinow, D. R. (2000). Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 157, 924–930.CrossRefGoogle ScholarPubMed
Bromberger, J. T. et al. (2007). Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). Journal of Affective Disorders, 103, 267–272.CrossRefGoogle Scholar
Campagne, D. M. and Campagne, D. M. (2007). The premenstrual syndrome revisited. European Journal of Obstetrics and Gynaecology and Reproductive Biology, 130, 4–17.CrossRefGoogle ScholarPubMed
Clavel-Chapelon, F. (2002). Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes and Control, 13, 831–838.CrossRefGoogle ScholarPubMed
Cohen, L. S., Soares, C. N., Poitras, J. R., Prouty, J., Alexander, A. B. and Shifren, J. L. (2003). Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. American Journal of Psychiatry, 160, 1519–1522.CrossRefGoogle ScholarPubMed
Erdincler, D., Bugay, G., Ertan, T. and Eker, E. (2004). Depression and sex hormones in elderly women. Archives of Gerontology and Geriatrics, 39, 239–244.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle ScholarPubMed
Harlow, B. L., Wise, L. A., Otto, M. W., Soares, C. N. and Cohen, L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Archives of General Psychiatry, 60, 29–36.CrossRefGoogle Scholar
Kalache, A., Maguire, A. and Thompson, S. G. (1993). Age at last full-term pregnancy and risk of breast cancer. The Lancet, 341, 33–36.CrossRefGoogle ScholarPubMed
Katz, S., Ford, A. B., Moskowitz, R. W. and Jaffee, M. W. (1963). Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA, 195, 94–99.Google Scholar
Key, T. J., Verkasalo, P. K. and Banks, E. (2001). Epidemiology of breast cancer. Lancet Oncology, 2, 133–140.CrossRefGoogle ScholarPubMed
Kotz, K., Alexander, J. L. and Dennerstein, L. (2006). Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women. Journal of Women's Health (Larchmont), 15, 898–908.CrossRefGoogle ScholarPubMed
Lawton, M. P. and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, 9, 179–186.CrossRefGoogle ScholarPubMed
Low, L. F., Anstey, K. J., Jorm, A. F., Rodgers, B. and Christensen, H. (2005). Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60–64 years. Climacteric, 8, 380–389.CrossRefGoogle Scholar
McLay, R. N., Maki, P. M. and Lyketsos, C. G. (2003). Nulliparity and late menopause are associated with decreased cognitive decline. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 161–167.CrossRefGoogle ScholarPubMed
Michaelsson, K., Baron, J. A., Farahmand, B. Y., Persson, I. and Ljunghall, S. (1999). Oral-contraceptive use and risk of hip fracture: a case-control study. The Lancet, 353, 1481–1484.CrossRefGoogle ScholarPubMed
Nguyen, T. V., Jones, G., Sambrook, P. N., White, C. P., Kelly, P. J. and Eisman, J. A. (1995). Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. Journal of Clinical Endocrinology and Metabolism, 80, 2709–2714.Google Scholar
Radloff, L. S. and Locke, B. Z. (1986). The community mental health assessment survey and CES-D scale. In Weissman, M. M. and Myers, J. K. (eds.), Community Surveys of Psychiatric Disorders. New Brunswick, NJ: Rutgers University Press.Google Scholar
Ribet, C. and Derriennic, F. (1999). Age, working conditions and sleep disorders: a longitudinal analysis in the French cohort E.S.T.E.V. Sleep, 22, 491–504.Google ScholarPubMed
Ritchie, K. et al. (2004). Prevalence of DSM-IV psychiatric disorder in the French elderly population. British Journal of Psychiatry, 184, 147–152.CrossRefGoogle ScholarPubMed
Schiff, R., Bulpitt, C. J., Wesnes, K. A. and Rajkumar, C. (2005). Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology, 30, 309–315.CrossRefGoogle ScholarPubMed
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F. and Rubinow, D. R. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. The New England Journal of Medicine, 338, 209–216.CrossRefGoogle ScholarPubMed
Steiner, M., Dunn, E. and Born, L. (2003). Hormones and mood: from menarche to menopause and beyond. Journal of Affective Disorders, 74, 67–83.CrossRefGoogle ScholarPubMed
Whooley, M. A., Grady, D. and Cauley, J. A. (2000). Postmenopausal estrogen therapy and depressive symptoms in older women. Journal of General Internal Medicine, 15, 535–541.CrossRefGoogle ScholarPubMed
Young, E. A., Midgley, A. R., Carlson, N. E. and Brown, M. B. (2000). Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry, 57, 1157–1162.CrossRefGoogle ScholarPubMed